Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
880.3000
-3.20
(
-0.36
%)
NSE
Jun 19, 2026
11:54 AM
28.24% Fall from 52W High
Volume:
617.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
19 Mar 2025, 12:00AM
880.30
-0.36%
NATCO PHARMA
Hold:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 887
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 254 to 285 in Mar 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market trades lower, Aurobindo Pharma gets US FTC nod to acquire Lannett for $250 mn
Trendlyne Marketwatch |
19 Jun 2026, 11:48AM
India Inc tests the tolerance of consumers for higher prices
The Baseline |
18 Jun 2026, 10:54AM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020, 06:25PM